ghk-cu scars for Keloid Research — Mechanism Evidence GHK-Cu Peptides Before and After:

One published case series (N=14 patients, mixed athletic backgrounds) noted that 11 of 14 participants reported reduced DOMS duration from an average of 72 hours to approximately 36 hours, though this was self-reported and uncontrolled

Its an excellent safeguard for patients who wish to ensure that peptide or hormone therapies are introduced in the safest possible context

It promotes angiogenesis and reduces inflammation, creating the conditions necessary for healing to begin

Research Stage: Tirzepatide is approved

The decline tracks with how skin and other tissue slows at repairing itself as the years accumulate